These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 18178603

  • 1. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
    Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.
    J Nephrol; 2010 Jun; 23(1):70-6. PubMed ID: 20091489
    [Abstract] [Full Text] [Related]

  • 3. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Jun; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 4. O-glycosylation of serum IgD in IgA nephropathy.
    Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Apr; 17(4):1192-9. PubMed ID: 16510764
    [Abstract] [Full Text] [Related]

  • 5. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin.
    Linossier MT, Palle S, Berthoux F.
    Am J Kidney Dis; 2003 Mar; 41(3):558-64. PubMed ID: 12612978
    [Abstract] [Full Text] [Related]

  • 6. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy.
    Ding JX, Xu LX, Lv JC, Zhao MH, Zhang H, Wang HY.
    Clin Immunol; 2007 Dec; 125(3):268-74. PubMed ID: 17913589
    [Abstract] [Full Text] [Related]

  • 7. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X, Ding J, Zhu L, Shi S, Jiang L, Zhao M, Zhang H.
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [Abstract] [Full Text] [Related]

  • 8. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
    van der Boog PJ, van Kooten C, van Seggelen A, Mallat M, Klar-Mohamad N, de Fijter JW, Daha MR.
    Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
    [Abstract] [Full Text] [Related]

  • 9. Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.
    Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.
    J Am Soc Nephrol; 2006 Dec; 17(12):3529-39. PubMed ID: 17050773
    [Abstract] [Full Text] [Related]

  • 10. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 11. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713
    [Abstract] [Full Text] [Related]

  • 12. Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.
    Iwatani H, Inoue T, Wada Y, Nagasawa Y, Yamamoto R, Iijima H, Takehara T, Imai E, Rakugi H, Isaka Y.
    Biochem Biophys Res Commun; 2012 Nov 23; 428(3):339-42. PubMed ID: 23098908
    [Abstract] [Full Text] [Related]

  • 13. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
    Satake K, Shimizu Y, Sasaki Y, Yanagawa H, Suzuki H, Suzuki Y, Horikoshi S, Honda S, Shibuya K, Shibuya A, Tomino Y.
    BMC Nephrol; 2014 Jun 13; 15():89. PubMed ID: 24928472
    [Abstract] [Full Text] [Related]

  • 14. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients.
    Itoh A, Iwase H, Takatani T, Nakamura I, Hayashi M, Kobayashi Y, Hiki Y, Okamoto M.
    J Nephrol; 2005 Jun 13; 18(5):575-81. PubMed ID: 16299684
    [Abstract] [Full Text] [Related]

  • 15. Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region.
    Hiki Y, Hori H, Yamamoto K, Yamamoto Y, Yuzawa Y, Kitaguchi N, Takahashi K.
    J Nephrol; 2015 Apr 13; 28(2):181-6. PubMed ID: 25037591
    [Abstract] [Full Text] [Related]

  • 16. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
    Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R.
    Clin J Am Soc Nephrol; 2011 Aug 13; 6(8):1903-11. PubMed ID: 21784819
    [Abstract] [Full Text] [Related]

  • 17. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC, Molyneux K, Feehally J, Barratt J.
    J Am Soc Nephrol; 2006 Dec 13; 17(12):3520-8. PubMed ID: 17093066
    [Abstract] [Full Text] [Related]

  • 18. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar 13; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 19. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
    Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH.
    Clin Exp Immunol; 2005 Dec 13; 142(3):569-75. PubMed ID: 16297170
    [Abstract] [Full Text] [Related]

  • 20. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
    Moldoveanu Z, Wyatt RJ, Lee JY, Tomana M, Julian BA, Mestecky J, Huang WQ, Anreddy SR, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J.
    Kidney Int; 2007 Jun 13; 71(11):1148-54. PubMed ID: 17342176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.